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Abstract Using a specific antibody against the PDP catalytic 
subunit, PDPc, precise localization of this subunit in mitochon-
dria was performed. Sub-fractionation of purified mitochondria 
by controlled swelling processes led to the isolation of outer 
membranes, matrix space and inner membrane vesicles which 
were purified on a sucrose density gradient. In this study, we 
demonstrated that PDPc was not recovered as a soluble protein 
in the matrix space but was associated with the inner membrane. 
Moreover, Triton X-114 phase partitioning performed on inner 
membranes showed that PDPc behaved both as a hydrophilic and 
as a hydrophobic protein, thus suggesting two different forms of 
this enzyme. 
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1. Introduction 
The pyruvate dehydrogenase multienzymatic complex 
(PDH), which catalyzes the oxidative decarboxylation of pyr-
uvate to form acetyl-CoA, is an important converter enzyme 
between the glycolytic pathway and either the tricarboxylic 
acid cycle with ATP synthesis or lipid biosynthesis. Such an 
enzymatic complex localized at a crucial metabolic point 
needs to be acutely controlled. PDH complex activity regula-
tion is achieved by both the reaction products and reversible 
phosphorylation. The PDH complex undergoes an intercon-
version between an active non-phosphorylated form (PDHa) 
and an inactive phosphorylated form (PDHb) [1]. The phos-
phorylation is catalyzed by a specific kinase tightly bound to 
dihydrolipoyl transacetylase (E2 component). Dephosphoryla-
tion and subsequent activation of the PDH is catalyzed by a 
Mg2+-dependent and Ca2+ -stimulated serine/threonine phos-
phatase. This phosphatase, which has proven over the years to 
be somewhat refractory to purification, has finally been pur-
ified from different sources [2-5]. This enzyme is a heterodi-
mer [2-4], which consists of a cloned catalytic subunit, PDPc, 
of Mv 52 600 which shares sequence homology with the pro-
tein phosphatase 2C family [6], and a regulatory subunit, 
PDPr, of MT 95 800 which is a flavoprotein thought to be 
involved in the insulin-induced signaling pathway, leading to 
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the activation of the PDH complex [7]. In eukaryotic cells, the 
PDH complex is localized in mitochondria within the inner 
membrane-matrix compartment. After mitochondria disrup-
tion and separation of mitochondrial membranes by centrifu-
gation, the PDH complex remains partially bound to the inner 
membrane [8,9]. Up to now, no precise localization of this 
enzymatic complex in mitochondria and no topological stud-
ies of this complex have been described although a better 
understanding of the organization of this enzymatic complex 
within mitochondria should facilitate studies on regulation of 
this enzyme. In this study, using a controlled sub-fractiona-
tion of purified liver mitochondria and an antibody raised 
against the amino-terminal sequence of PDPc, we prove that 
PDPc does not exist as a soluble matrix protein but tightly 
interacts with mitochondrial inner membrane, where this en-
zyme is uniformly distributed. 
2. Materials and methods 
2.1. Preparation and purification of mitochondrial membranes 
Mouse liver mitochondria, outer membrane vesicles and mitoplasts 
were prepared as previously described [10]. Mitoplasts were subjected 
to swelling in 1 mM potassium phosphate buffer pH 7.4 at 4°C, and 
centrifugation at 100000Xg for 1 h led to obtaining inner membrane 
vesicles (pellet) and matrix space (supernatant) which was lyophilized 
and stored at —20°C. Inner membrane vesicles were purified on a 
discontinuous sucrose gradient (41%, 44.5%, 47.9%, 51.3%) and 
61.5%>). After centrifugation at 25 000 rpm (rotor SW28) for 2 h, 
four membranous fractions were collected, washed in 10 mM Tris-
HCl pH 7.5 buffer and stored in liquid nitrogen. Protein concentra-
tion in the different fractions was determined according to the Gor-
nall's procedure [11]. To detect ultramicro amounts of proteins, the 
method of Schaffner and Weissmann [12] was used. 
2.2. Marker enzyme assays 
Monoamine oxidase (EC 1.4.3.4), as outer membrane marker en-
zyme, cytochrome c oxidase (EC 1.9.3.1), as inner membrane marker 
enzyme, basic 5'-nucleotidase (EC 3.1.3.5), as plasma membrane mar-
ker enzyme and glucose-6 phosphate phosphatase (EC 3.1.3.9), as 
rough endoplasmic reticulum marker enzyme were assayed as pre-
viously described [10]. Citrate synthase (EC 4.1.3.7), as matrix space 
marker enzyme was assayed according to Srere [13]. 
2.3. Electrophoretic procedures 
For mitochondrial proteins, SDS-PAGE was performed under re-
ducing conditions according to the method of Laemmli [14], using a 
10%o separating gel at a voltage of 200 V for 45 min. Two-dimensional 
electrophoresis was carried out according to O'Farrel [15] with 1.6% 
of ampholines pH 5-7 and 0.4%> of ampholines pH 3-10 for 5 h at 750 
V using a BioRad apparatus. Pi range was calibrated with a calibra-
tion kit (BioRad). 
2.4. Immunological procedures 
2.4.1. Production of a specific antibody against amino-terminal se-
quence of PDPc. This specific antibody was prepared by Covalab 
using the amino-terminal peptide sequence (ASTPQKFYLTPPQVN) 
of the mature catalytic subunit of bovine PDPc described by Lawson 
et al. [6] and used for rabbit immunization. Before injection, 5 ml of 
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blood was collected as preimmune control serum. Immunization was 
performed by a subcutaneous and muscular multi-injection technique 
each time with 0.5 mg of synthetic peptide coupled to a carrier protein 
and emulsified with an equal volume of Freund's adjuvant for the first 
immunization and without adjuvant for the booster injections. Di-
luted immune serum was used as a source of antibodies without 
further purification. 
2.4.2. Immunoblotting. SDS-PAGE or 2D-electrophoresis sepa-
rated proteins were electro- transferred onto nitrocellulose sheets. 
The sheets were incubated overnight at +4°C in TSN buffer contain-
ing 3% BSA to block non-specific antibody binding. The sheets were 
then incubated for 90 min in the presence of anti-N-PDPc antibody 
diluted to 1/3000 in TSN containing 0.25% BSA (buffer I), and 
washed three times in TSN. The immunological study was performed 
using anti-rabbit IgG peroxidase-labeled (diluted to 1/2000 in buffer I) 
and chemiluminescent visualization (Covalab kit). 
2.5. Protein staining 
Proteins were stained with a silver nitrate method using the Silver 
Stain Plus kit (BioRad) on SDS-PAGE and with Ponceau red on 
nitrocellulose sheets. 
2.6. Treatment with increasing salt concentrations 
Samples of IM3 fraction (25 μg) were incubated for 30 min at +4°C 
in 50 μΐ of 10 mM Tris-HCl pH 7.4 containing increasing concentra-
tions of NaCl, from 50 to 500 mM. After centrifugation, solubilized 
proteins (supernatant) and membranous proteins (pellet) were col-
lected and acetone precipitated. 
2.7. Triton X-114 phase partitioning of proteins 
Mitochondrial membranes (100 μg proteins in 100 μΐ) were incu-
bated in 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA 
containing 2% of precondensed Triton X-114 [16] at +4°C for 15 
min and phase partitioning was performed according to the method 
described by Bordier [16], slightly modified. Briefly, after incubation 
at 37°C for 10 min, the different samples were centrifuged at 
10000Xg for 1 min in a microfuge. The phases were separated and 
50 μΐ of 4% ice-cold Triton X-114 and 50 μΐ of ice-cold theoretical 
upper phase containing 0.06% Triton X-114 were added to the upper 
and lower phase, respectively. After a second phase partitioning, 
aqueous and detergent-rich phases were pooled and proteins of each 
phase were acetone precipitated. 
3. Results 
3.1. Purification of mitochondrial membranes 
In an at tempt to investigate the localization of the P D H 
phosphatase in mitochondria, we prepared sub-mitochondrial 
compartments, outer membranes, inner membranes and ma-
trix space. Mouse liver mitochondria were purified using a 
mild ultra-sonic treatment, which eliminates contaminant 
membranes, as previously described by our group [10]. Total 
outer membranes were obtained after a controlled osmotic 
shock on purified mitochondria as described [10], followed 
by high speed centrifugation, while total inner membranes 
and matrix space were obtained after swelling of mitoplasts 
Fig. 1. SDS-PAGE and Western blot analysis of sub-mitochondrial 
fractions. A: Separation of mitochondrial proteins (5 μg) on 10% 
SDS-PAGE and staining with silver nitrate. B: Immunodetection of 
mitochondrial proteins (20 μg) with anti N-PDPc antibody, after 
electroblotting on nitrocellulose sheets. Lane 1: IMi fraction; lane 
2: IM2 fraction; lane 3: IM3 fraction; lane 4: IM4 fraction; lane 5: 
matrix space; lane 6: outer membranes. 
in 1 m M phosphate buffer and high speed centrifugation. 
Matrix space was constituted of soluble proteins released after 
this swelling and inner membrane vesicles, obtained in the 
pellet, were further purified on a discontinuous sucrose gradi-
ent. Four fractions of inner membrane vesicles were resolved 
after centrifugation and named fractions IMi to IM4 from the 
top to the bot tom of the gradient. According to the mitochon-
drial specific marker enzymes, monoamine oxidase, cyto-
chrome c oxidase and citrate synthase, fractions IMi and 
IM 2 were characterized by the presence of these three enzy-
matic activities (Table 1), thus corresponding to vesicles where 
outer membrane and inner membrane were both present and 
closely associated forming probably transitional contact sites. 
The citrate synthase activity measured in fractions I M ! and 
Table 1 
Marker enzyme activities in mitochondrial membrane fractions 
Marker enzymes Outer membranes Inner membranes Fraction IMi 
36.9 
2050 
170 
0.67 
115 
Fraction IM2 
28.8 
3800 
230 
0.15 
7 
Fraction IM3 
9.2 
2310 
340 
0.02 
ND 
Fraction IM4 
1.15 
980 
240 
ND 
ND 
Mitochondrial markers 
Monoamine oxidase 61.15 
Cytochrome c oxidase 900 
Citrate synthase nd 
Non-mitochondrial markers 
Basic 5'-nucleotidase 3.12 
Glucose 6-phosphate phosphatase nd 
24.23 
250 
0.34 
11 
Specific activities of monoamine oxidase, cytochrome c oxidase, citrate synthase, glucose 6-phosphate phosphatase are expressed as nmol min 
mg - 1 . Specific activity of basic 5'-nucleotidase is expressed as pmole min - 1 mg - 1 . ND: not detectable; nd: not determined. 
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Fig. 2. 2D PAGE electrophoresis and Western blot analysis of sub-
mitochondrial fractions. A: 2D-electrophoretic pattern of the IM3 
fraction: 30 μg of IM3 fraction was analyzed by 2D SDS-PAGE 
(10% acrylamide) according to O'Farrel. Protein spots were visual-
ized with silver nitrate. Pi were calibrated by the migration of 
standard proteins alone in the same conditions. B: 2D PAGE elec-
trophoresis and immunoblotting of IM3 fraction: 30 μg of IM3 
fraction were analyzed by 2D SDS-PAGE. After electrotransfer on 
nitrocellulose sheets, proteins spots were analyzed with the anti N-
PDPc antibody. 
IM2 was probably due to the specific binding of this enzyme 
to the inner side of the inner mitochondrial membrane, in the 
low ionic strength conditions that were used for the swelling 
of mitoplasts [17], rather than reflecting a high content of 
matrix proteins in both fractions. Moreover, it is worth noting 
that enrichment of cytochrome c oxidase and citrate synthase 
activities increased in correlation with the decrease of mono-
amine oxidase activities in fractions IM! and IM2 (Table 1). 
Fractions IM3 and IM4 contained almost exclusively citrate 
synthase and cytochrome c oxidase activities and were devoid 
of non-mitochondrial membranes and outer membranes, as 
specific activities of basic 5'-nucleotidase, glucose-6 phosphate 
phosphatase and monoamine oxidase were very low or unde-
tectable (Table 1). These two fractions corresponded to vesi-
cles of purified inner membranes containing matrix proteins, 
although we noted a decrease in cytochrome c oxidase activ-
ity. Fractions IM3 and IM4 were further used as pure inner 
membrane. 
3.2. Sub-mitochondrial localization of PDPc 
Each of the soluble or membranous sub-mitochondrial frac-
tions was analyzed by SDS-PAGE using silver nitrate colora-
tion (Fig. 1A) and by immunoblotting using a polyclonal 
antiserum raised against the amino-terminal sequence of the 
catalytic subunit of the PDH phosphatase, N-PDPc (Fig. IB). 
We detected two specific proteins, one of 55 kDa which is the 
PDPc protein, and a protein of 80 kDa with hitherto un-
known function (Fig. IB). Both were present in all the inner 
membrane vesicles and were completely absent from the ma-
trix space. However, on the one hand, the 80 kDa protein 
appeared to be less abundant in fraction IM4 than in other 
lighter IM fractions and on the other hand, a protein of 58 
kDa was detected at a low level in all IM fractions and in 
matrix space. This latter protein should be the imported form 
of the PDPc protein which possessed the mitochondrial im-
port presequence [6]. Moreover, the outer membrane fraction 
contained only the 55 kDa protein, detected by the antibody. 
As this fraction corresponded to a total outer membrane frac-
tion, without further separation on a sucrose gradient, it con-
tained also inner membrane parts as previously described [10], 
which could account for the signal observed with the anti N-
PDPc antibody. The antibody specificity was checked by pre-
incubation of the antiserum with the immune peptide prior to 
the immunological clarification of proteins on the nitrocellu-
lose sheet. The immunological detection was completely abol-
ished by this treatment (data not shown). Moreover, control 
experiments performed either with pre-immune serum or with 
the second antibody alone did not permit any detection (data 
not shown). To further characterize the two specific mitochon-
drial proteins of 55 and 80 kDa, we analyzed them by 2D-
electrophoresis and we chose fraction IM3 which is a pure 
inner membrane fraction where both proteins were largely 
detected. Fraction IM3 proteins were separated in a range 
of pH from 7 to 4.5 (Fig. 2A) and two spots were detected 
with the anti N-PDPc antibody; the 80 kDa protein had a Pi 
around pH 6, whereas the PDPc protein Pi was around pH 5 
(Fig. 2B). This result is in agreement with the theoretical 
PDPc Pi of 5.5, calculated from its sequence. To gain further 
insight into the properties of these mitochondrial proteins, we 
studied their association with the inner membrane either by 
treatment of the membrane with increasing salt concentrations 
or by Triton X-114 temperature-induced phase separation. 25 
μg of fraction IM3 was incubated in the presence of several 
concentrations of NaCl. Membranous and solubilized pro-
Fig. 3. Treatment of inner membrane with increased salt concentra-
tions. Samples of IM3 fraction (25 μg) were incubated for 30 min at 
+4°C in presence of increased concentrations of NaCl (from 50 mM 
to 500 mM). After centrifugation, soluble proteins (supernatant, 
lanes S) and membranous proteins (pellet, lanes P) were collected 
and analyzed by SDS-PAGE, immunoblotting and anti N-PDPc 
antibody revelation. Pl/Sl: 50 mM NaCl; P2/S2: 150 mM NaCl; 
P3/S3: 250 mM NaCl; P4/S4: 500 mM. 
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Fig. 4. Triton X-114 phase partitioning. A sample of IM3 fraction 
(25 μg) was incubated for 10 min at 37°C and submitted twice to 
Triton X-114 phase partitioning. Soluble hydrophilic proteins (lane 
1) and insoluble hydrophobic proteins (lane 2) were collected and 
analyzed by SDS-PAGE, immunoblotting and anti N-PDPc anti-
body revelation. 
teins were analyzed by SDS-PAGE and immunoblotting with 
the anti N-PDPc antibody. The results (Fig. 3) showed that 
PDPc was slightly solubilized by a concentration of 50 mM 
NaCl (Fig. 3, lane SI) and that the solubilization increased 
with salt concentration (lanes S1-S4), correlating with a de-
crease of the detection of this protein in the membranous 
pellet (Fig. 3, lanes P1-P4). The efficiency of the salt solubil-
ization of fraction IM was improved using NaCl concentra-
tions up to 0.5 M. Even in these conditions, PDPc (protein of 
55 kDa) did not appear completely as a soluble form, whereas 
the salt treatment did not succeed in solubilizing the 80 kDa 
protein (Fig. 3). Triton X-114 phase partitioning, which is a 
convenient method to distinguish between amphipathic, inte-
gral and hydrophilic proteins, was also achieved on inner 
mitochondrial membranes. After incubation at 37°C, hydro-
philic proteins collected in the aqueous phase and hydropho-
bic proteins collected in the detergent phase were analyzed by 
SDS-PAGE and immunodetection was performed with the 
anti N-PDPc antibody. Fig. 4 showed that the PDPc protein 
was recovered after phase partitioning both in the aqueous 
phase (Fig. 4, lane 1) and in the detergent phase (Fig. 4, 
lane 2) with the same apparent detection intensity, whereas 
the 80 kDa protein was only detected in the detergent phase 
as a standard hydrophobic protein (Fig. 4, lane 2). No detec-
tion of this latter protein was observed in the aqueous phase 
(Fig. 4, lane 1). 
4. Discussion 
Up to now, very few studies concerning the purification of 
the PDP have been performed [2-5]. The procedure steps in-
volved treatments such as freezing or sonication of the mito-
chondria, which are known to cause irreversible modification 
of protein/membrane organization, not allowing any conclu-
sions about the PDP sub-localization in mitochondria. The 
aim of this study was therefore to purify and to characterize 
sub-mitochondrial compartments in order to specify the PDPc 
repartition in this organelle using a specific antibody. Our 
results clearly indicate that the catalytic subunit of the enzyme 
(protein of 55 kDa) was not present in the outer membrane or 
as a soluble protein in the matrix space but was widely dis-
tributed throughout the mitochondrial inner membrane. The 
same localization was also observed for a specifically detected 
80 kDa protein of unknown function. 
Moreover, it is worth noting that the PDPc protein pre-
sented a biphasic behavior during Triton X-114 phase parti-
tioning, as the enzyme was recovered both in the aqueous 
phase and in the detergent-rich phase, in the same amount 
according to the intensity of the antibody detection. On the 
other hand, the same method showed that the 80 kDa protein 
was only present in the detergent-rich phase, as a hydrophobic 
protein [16]. In addition, the spot observed for the 55 kDa 
protein in 2D-electrophoresis led us to conclude that the 55 
kDa proteins, recovered in both aqueous and detergent 
phases, were not two different proteins with the same appar-
ent molecular weight and sharing sequence homology, but 
could be two different forms of the same protein. These two 
forms should differ by minor characteristics, which do not 
affect their electrophoretic mobility but are sufficient to mod-
ify their interaction with the inner mitochondrial membrane. 
Hydrolysis of a short peptide sequence, as previously de-
scribed for another protein [18], or a post-translational mod-
ification such as acylation [19] could explain such results, 
which are also confirmed by the fact that only a part of the 
PDPc content was solubilized by incubation of inner mem-
brane in 1 M NaCl (data not shown), the remainder remain-
ing stably associated with the membrane. 
The anti N-PDPc antibody used in this work led us first to 
prove the PDPc sub-localization in mitochondria and pro-
vides a powerful tool for further studies on PDP regulation, 
particularly in conditions of enzyme activation by a putative 
intracellular mediator in response to insulin action [20]. 
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